SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aviron
AVIR 3.490+3.4%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brad C. Dunlap who wrote (102)8/3/1997 1:08:00 PM
From: David   of 645
 
Brad, Mr Ni cited your original words from your post but you say he is twist the facts. Please go to read your first post at Sunday, July 27th. >>> I understand that Sturza came out with a strong buy recommendation on Friday and based on the 300 million market cap for a
company at the later stages of the fda cycle<<<. Please read it carefully. You said Friday not the day before Friday.

Now you say >>> H&Q released their buy recommendation a day or two
after the results of the phase III study were publically released<<<.

Please tell readers which one is right??????

I checked the insiders trading, which shows the president, CEO of AVIR is also involving the insiders sell.

The quarterly finacial report can't been found from their SEC filing. Can you tell us the rule? Does AVIR need publically report their finacial results or not?

I could not find out the website of this great company. Can you tell me the address.

Thanks for your truthful reply in advance.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News